NCT03507426 is a NA clinical trial of Retrobulbar block in Enucleated; Eye, sponsored by Nazmy Edward Seif.

Who is sponsoring NCT03507426?

NCT03507426 is sponsored by Nazmy Edward Seif.

What drugs are being tested in NCT03507426?

Interventions in NCT03507426: Retrobulbar block, Ketamine.

What condition does NCT03507426 study?

NCT03507426 studies Enucleated; Eye, Evisceration; Operation Wound, Pain, Postoperative.

Is NCT03507426 still recruiting?

NCT03507426 is currently completed. Last updated 14 July 2020.

Last reviewed 2020-07-14 · How we verify

NCT03507426

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Retrobulbar Block Versus Ketamine Infusion for Post-enucleation Analgesia

Completed NA Last updated 14 July 2020

What this trial tests

NA trial testing Retrobulbar block in Enucleated; Eye in 45 participants. Completed in 31 March 2020.

Timeline

25 April 2018

Primary endpoint
31 March 2020

31 March 2020

Quick facts

Lead sponsor	Nazmy Edward Seif
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	45
Start date	25 April 2018
Primary completion	31 March 2020
Estimated completion	31 March 2020
Sites	1 location across Egypt

Drugs / interventions tested

Retrobulbar block
Ketamine (ketamine) — full drug profile →

Conditions studied

Enucleated; Eye — all drugs for Enucleated; Eye →
Evisceration; Operation Wound — all drugs for Evisceration; Operation Wound →
Pain, Postoperative — all drugs for Pain, Postoperative →

Sponsor

Nazmy Edward Seif — full company profile →

Who can join

18 and older, any sex, with Enucleated; Eye or Evisceration; Operation Wound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compares the efficacy and safety of two techniques, retrobulbar block versus intra-operative ketamine infusion, for control of post-operative pain occurring in patients undergoing ocular enucleation or evisceration performed under general anesthesia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparative Study of Retrobulbar Block versus Ketamine Infusion during Eye Enucleation/Evisceration (Randomized Controlled Trial).
Ali HM, Elbadawy AM. · · 2020 · PMID 32843800 · DOI 10.4103/aer.aer_146_19

Verify or expand the search:

Other Nazmy Edward Seif trials

Trials by the same sponsor.

NCT05278598 — 3 Ultrasound Guided Plane Blocks for Perioperative Analgesia in Patients Undergoing Radical Cystectomy · NA · completed
NCT04998435 — Paravertebral Block Versus Erector Spinae Plain Block In Percutaneous Nephrolithotomy · NA · completed
NCT04800302 — U/S-guided Continuous Quadratus Lumborum Block III in Percutaneous Nephrolithotomy · NA · completed
NCT04518215 — Erector Spinae Plane Block for Paediatric Upper Abdominal Surgery · NA · completed
NCT04519268 — Adherence Degree of Kasr-Alaini Hospital Pre-anesthetic Tests to the NICE-UK Guidelines · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03507426 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nazmy Edward Seif
Last refreshed: 14 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03507426.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing